Parkinson’s doesn’t just affect movement and the brain—it may also impact the heart, according to new research from the University of Surrey. Scientists from Surrey’s School of Veterinary Medicine suggest that targeting a key protein outside of the brain could help manage Parkinson’s-related heart issues.

In a study published in Experimental Physiology, Surrey researchers studied mouse models and found a harmful buildup of the alpha-synuclein protein, which is associated with Parkinson’s disease, in a nerve cluster near the heart (the stellate ganglia). These nerves are part of the autonomic nervous system, which controls heart rate and rhythm.

Researchers found that 27% of neurons in the nerve cluster contained aggregated alpha-synuclein, forming similar toxic clumps seen in the brains of Parkinson’s patients. This finding suggests that Parkinson’s could disrupt heart function, not just movement and brain activity.

Differences in the distribution of certain proteins and markers in the brain may explain why some people first experience vision changes instead of memory loss in Alzheimer’s disease, finds a new study by UCL researchers.

Posterior cortical atrophy (PCA) is a rare form of Alzheimer’s disease that, rather than causing problems with memory, leads to difficulties with reading, navigating, and recognizing objects. Studies suggest that one in 10 patients with Alzheimer’s disease has a form which is visual, rather than memory-led.

As well as presenting with unusual symptoms, individuals with PCA typically develop symptoms younger than most people with Alzheimer’s disease, with onset usually in their 50s and 60s.

Using a natural experiment that avoids common bias concerns, this study finds that the live-attenuated shingles vaccine reduced the probability of a new dementia diagnosis within a follow-up period of 7 years by approximately one-fifth.